5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidin-4(3H)-one
≥97%
- Product Code: 82570
CAS:
756437-41-9
| Molecular Weight: | 151.17 g./mol | Molecular Formula: | C₇H₉N₃O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD08273930 | |
| Melting Point: | Boiling Point: | 418.6 °C at 760 mmHg | |
| Density: | Storage Condition: | 2-8°C |
Product Description:
This compound is widely utilized in pharmaceutical research and development, particularly as a key intermediate in the synthesis of various bioactive molecules. Its structural framework is often incorporated into compounds designed to target specific enzymes or receptors, making it valuable in drug discovery. It has shown potential in the development of kinase inhibitors, which are crucial in treating diseases such as cancer, inflammatory disorders, and autoimmune conditions. Additionally, its derivatives are being explored for their therapeutic effects in neurological and cardiovascular diseases. The compound's versatility in chemical modifications allows researchers to optimize its properties for enhanced efficacy and selectivity in drug candidates.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.250 | 10-20 days | ฿21,600.00 |
+
-
|
| 1.000 | 10-20 days | ฿43,245.00 |
+
-
|
5,6,7,8-Tetrahydropyrido[4,3-d]pyrimidin-4(3H)-one
This compound is widely utilized in pharmaceutical research and development, particularly as a key intermediate in the synthesis of various bioactive molecules. Its structural framework is often incorporated into compounds designed to target specific enzymes or receptors, making it valuable in drug discovery. It has shown potential in the development of kinase inhibitors, which are crucial in treating diseases such as cancer, inflammatory disorders, and autoimmune conditions. Additionally, its derivatives are being explored for their therapeutic effects in neurological and cardiovascular diseases. The compound's versatility in chemical modifications allows researchers to optimize its properties for enhanced efficacy and selectivity in drug candidates.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :